Market Overview:
The global bloodstream infection testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of bloodborne infections, growing demand for rapid and accurate diagnosis, and technological advancements in blood culture systems. The medical equipment segment is expected to account for the largest share of the global bloodstream infection testing market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030.
Product Definition:
Bloodstream infection testing is the process of checking a person's blood for the presence of infection. This type of testing can be used to diagnose an infection, to determine how severe an infection is, or to track the progress of an illness. Bloodstream infections are serious illnesses that can cause significant health problems if not treated properly. Early diagnosis and treatment is essential for preventing long-term health complications.
Medical Equipment:
Medical equipment is any device or product which helps in diagnosing, curing or mitigating a disease. It includes diagnostic as well as therapeutic devices. The medical device industry is expected to grow at a lucrative rate over the forecast period owing to factors such as increasing prevalence of chronic diseases and rising demand for home healthcare services.
Detection Reagent:
Detection reagent is a specialized solution that facilitates the detection of pathogens in the blood. Detection reagents are used for testing various infections in animals and humans. These solutions are also used for detecting viruses, bacteria, toxins & chemicals and other microorganisms present in the blood or body fluids such as urine, saliva & semen.
Application Insights:
The market is segmented based on application into hospital, clinic, medical center and other. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a large patient base with various conditions requiring frequent blood stream infection testing. Moreover, an increase in healthcare expenditure globally has led to an increased number of hospitals which has further driven the growth of this segment. According to WHO, global healthcare expenditure was estimated at USD 9paralleled trillion in 2016 and is expected to reach USD 11nearly equitable trillion by 2030. This trend is projected to fuel demand for bloodstream infection testing over the forecast period thus driving demand for R&D activities pertaining towards its development over the coming years.
Clinical diagnosis plays a significant role during disease outbreak identification & control as it provides faster results than traditional methods such as microscopy or culture techniques used before modern diagnostic tests were developed due these tests being more accurate.
Regional Analysis:
North America dominated the global bloodstream infection testing market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and rising incidence of HAIs are some major factors responsible for its large share. Moreover, increasing government initiatives to raise awareness regarding early diagnosis is expected to fuel the market growth over the forecast period. For instance, in February 2018, a collaboration was launched by Public Health England (PHE) and National Blood Service (NBS) to increase awareness about blood stream infections across all 50 states in the U.S.
Growth Factors:
- Increasing incidence of bloodstream infections: The incidence of bloodstream infections is increasing globally due to the growing population and the increase in number of patients with underlying diseases. This is driving the demand for bloodstream infection testing products and services.
- Growing awareness about bloodborne pathogens: There is a growing awareness among people about bloodborne pathogens and their transmission routes, which is driving the demand for bloodstream infection testing products and services.
- Technological advancements in diagnostics: There has been a significant advancement in diagnostic technologies over the past few years, which has led to increased accuracy and efficiency of tests for detecting bloodstream infections. This is fueling the growth of the market for bloodstream infection testing products and services.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bloodstream Infection Testing Market Research Report
By Type
Medical Equipment, Detection Reagent
By Application
Hospital, Clinic, Medical Center, Other
By Companies
Abbott, BD, bioMerieux, Danaher, F. Hoffmann-La Roche, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Bloodstream Infection Testing Market Report Segments:
The global Bloodstream Infection Testing market is segmented on the basis of:
Types
Medical Equipment, Detection Reagent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Medical Center, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- BD
- bioMerieux
- Danaher
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
Highlights of The Bloodstream Infection Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medical Equipment
- Detection Reagent
- By Application:
- Hospital
- Clinic
- Medical Center
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bloodstream Infection Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bloodstream infection testing is a procedure used to determine if someone has contracted a bacterial infection in their bloodstream. This can be done through a series of tests that measure the levels of certain bacteria in the blood.
Some of the major companies in the bloodstream infection testing market are Abbott, BD, bioMerieux, Danaher, F. Hoffmann-La Roche, Thermo Fisher Scientific.
The bloodstream infection testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bloodstream Infection Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bloodstream Infection Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bloodstream Infection Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bloodstream Infection Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bloodstream Infection Testing Market Size & Forecast, 2020-2028
4.5.1 Bloodstream Infection Testing Market Size and Y-o-Y Growth
4.5.2 Bloodstream Infection Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Medical Equipment
5.2.2 Detection Reagent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Medical Center
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bloodstream Infection Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bloodstream Infection Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Medical Equipment
9.6.2 Detection Reagent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Medical Center
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Medical Equipment
10.6.2 Detection Reagent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Medical Center
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Medical Equipment
11.6.2 Detection Reagent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Medical Center
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Medical Equipment
12.6.2 Detection Reagent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Medical Center
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Medical Equipment
13.6.2 Detection Reagent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Medical Center
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bloodstream Infection Testing Market: Competitive Dashboard
14.2 Global Bloodstream Infection Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 BD
14.3.3 bioMerieux
14.3.4 Danaher
14.3.5 F. Hoffmann-La Roche
14.3.6 Thermo Fisher Scientific
